Cancers (Jul 2021)

Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset

  • Caroline Himbert,
  • Jane C. Figueiredo,
  • David Shibata,
  • Jennifer Ose,
  • Tengda Lin,
  • Lyen C. Huang,
  • Anita R. Peoples,
  • Courtney L. Scaife,
  • Bartley Pickron,
  • Laura Lambert,
  • Jessica N. Cohan,
  • Mary Bronner,
  • Seth Felder,
  • Julian Sanchez,
  • Sophie Dessureault,
  • Domenico Coppola,
  • David M. Hoffman,
  • Yosef F. Nasseri,
  • Robert W. Decker,
  • Karen Zaghiyan,
  • Zuri A. Murrell,
  • Andrew Hendifar,
  • Jun Gong,
  • Eiman Firoozmand,
  • Alexandra Gangi,
  • Beth A. Moore,
  • Kyle G. Cologne,
  • Maryliza S. El-Masry,
  • Nathan Hinkle,
  • Justin Monroe,
  • Matthew Mutch,
  • Cory Bernadt,
  • Deyali Chatterjee,
  • Mika Sinanan,
  • Stacey A. Cohen,
  • Ulrike Wallin,
  • William M. Grady,
  • Paul D. Lampe,
  • Deepti Reddi,
  • Mukta Krane,
  • Alessandro Fichera,
  • Ravi Moonka,
  • Esther Herpel,
  • Peter Schirmacher,
  • Matthias Kloor,
  • Magnus von Knebel-Doeberitz,
  • Johanna Nattenmueller,
  • Hans-Ulrich Kauczor,
  • Eric Swanson,
  • Jolanta Jedrzkiewicz,
  • Stephanie L. Schmit,
  • Biljana Gigic,
  • Alexis B. Ulrich,
  • Adetunji T. Toriola,
  • Erin M. Siegel,
  • Christopher I. Li,
  • Cornelia M. Ulrich,
  • Sheetal Hardikar

DOI
https://doi.org/10.3390/cancers13153817
Journal volume & issue
Vol. 13, no. 15
p. 3817

Abstract

Read online

Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (n = 2193). We calculated descriptive statistics and assessed associations of clinicodemographic factors with age of onset using mutually-adjusted logistic regression models. Patients were on average 60 years old, with BMI of 29 kg/m2, 52% colon cancers, 21% early-onset, and presented with stage II or III (60%) disease. Early-onset patients presented with more advanced disease (stages III–IV: 63% vs. 51%, respectively), and received more neo and adjuvant treatment compared to late-onset patients, after controlling for stage (odds ratio (OR) (95% confidence interval (CI)) = 2.30 (1.82–3.83) and 2.00 (1.43–2.81), respectively). Early-onset rectal cancer patients across all stages more commonly received neoadjuvant treatment, even when not indicated as the standard of care, e.g., during stage I disease. The odds of early-onset disease were higher among never smokers and lower among overweight patients (1.55 (1.21–1.98) and 0.56 (0.41–0.76), respectively). Patients with early-onset colorectal cancer were more likely to be diagnosed with advanced stage disease, to have received systemic treatments regardless of stage at diagnosis, and were less likely to be ever smokers or overweight.

Keywords